Wellbutrin (bupropion) is generally one of the better-tolerated antidepressants available, largely because it avoids the side effects that make many people quit other options: sexual dysfunction, weight gain, and drowsiness. That said, it comes with its own set of side effects, and whether it feels tolerable depends on your sensitivity to stimulating effects like insomnia and restlessness.
Why Wellbutrin’s Side Effect Profile Is Different
Most antidepressants work by increasing serotonin activity in the brain. Wellbutrin doesn’t. It boosts norepinephrine and dopamine instead, with no meaningful serotonergic effects. This distinction is the single biggest reason it’s tolerated differently from SSRIs like sertraline (Zoloft) or escitalopram (Lexapro).
Because serotonin-based antidepressants are strongly linked to sexual dysfunction, weight gain, and sedation, Wellbutrin sidesteps all three. Sexual dysfunction is four to six times more likely with serotonin-affecting antidepressants than with bupropion, which carries the lowest risk in its class. The Mayo Clinic lists it among the antidepressants least likely to cause sexual side effects. It’s also weight-neutral for most people, and in those who start above their ideal body weight, it’s associated with modest weight loss proportional to starting size. And unlike many antidepressants, it doesn’t cause daytime drowsiness. In clinical trials, sedation rates were no different from placebo.
The Side Effects It Does Cause
Wellbutrin trades the serotonin-related side effects for a different profile, one that leans more stimulating. The two most consistent issues in clinical trials are insomnia and dry mouth.
In dose-response trials of the sustained-release (SR) formulation, insomnia affected 31% of people on doses up to 300 mg per day, compared to 21% on placebo. At 300 mg specifically, that number rose to 40%, versus 18% on placebo. Dry mouth appeared in about 10 to 11% of users versus 4 to 5% on placebo. Nausea occurred in roughly 9% of people at 300 mg per day, compared to 4% on placebo.
In longer trials of the extended-release (XL) formulation lasting up to six months, the pattern held. Dry mouth affected 26% of users (versus 15% on placebo), insomnia 20% (versus 13%), headache 34% (versus 26%), nausea 13% (versus 8%), and constipation 9% (versus 2%). Anxiety appeared in 7% versus 5% on placebo.
Restlessness and Agitation Early On
One side effect that catches people off guard is a sense of restlessness or agitation, particularly in the first weeks. In trials of the original immediate-release formulation, about 32% of patients reported agitation, compared to 22% on placebo. A “substantial proportion” of users experience some degree of increased restlessness, anxiety, and insomnia shortly after starting treatment. For most, this settles over time. In roughly 2% of patients, these symptoms were severe enough that they stopped taking the medication.
This is one reason prescribers typically start at a low dose and increase gradually. The initial adjustment period can feel jittery or overstimulating, but it often smooths out within a few weeks. If you already deal with significant anxiety, this early activation effect is worth discussing with your prescriber before starting.
Seizure Risk at Higher Doses
The most serious tolerability concern with Wellbutrin is seizures, though the actual risk is low at standard doses. At 450 mg per day or less, seizures occur in roughly 0.35% to 0.44% of patients. That risk increases approximately tenfold at doses of 600 mg per day or higher, which is why there’s a firm ceiling on prescribed doses.
Certain conditions raise this risk further. Wellbutrin is contraindicated if you have a seizure disorder, a current or past diagnosis of bulimia or anorexia nervosa (where higher seizure rates were observed), or if you’re abruptly stopping alcohol, benzodiazepines, or barbiturates. These aren’t just precautions; they’re hard contraindications.
Long-Term Tolerability
Wellbutrin has been studied in maintenance treatment lasting up to 44 weeks for major depression and up to six months for seasonal affective disorder. In the seasonal depression trials, about 59% of patients stayed on treatment for three to six months, and the side effect profile during that time was consistent with what’s seen in shorter trials. No new or worsening side effects emerged with extended use, which is reassuring if you’re considering it as a long-term option.
The side effects that do appear, like dry mouth and insomnia, tend to either persist at a manageable level or improve as your body adjusts. Weight neutrality is maintained over time, which is a meaningful advantage over SSRIs and other antidepressants where gradual weight gain is a common reason people eventually stop treatment.
Who May Not Tolerate It Well
Wellbutrin isn’t a good fit for everyone. People with pre-existing anxiety disorders sometimes find the stimulating quality makes their anxiety worse rather than better. Those with a history of eating disorders are excluded due to increased seizure risk. It’s also contraindicated in people with severe liver or kidney dysfunction, and in those with narrow-angle glaucoma.
Like all antidepressants, Wellbutrin carries a boxed warning about increased suicidal thoughts and behavior in people under 25. Pooled data across antidepressant trials shows 14 additional cases per 1,000 patients treated among those under 18, and 5 additional cases per 1,000 among those aged 18 to 24. In adults 25 to 64, there was no increased risk, and in adults 65 and older, antidepressants were associated with 6 fewer cases per 1,000. This warning applies to the class of antidepressants broadly, not to bupropion specifically.
How It Compares Overall
For people whose main concern is avoiding sexual side effects, weight gain, or fatigue, Wellbutrin is often the most tolerable antidepressant option. Its dropout rates due to side effects in clinical trials were similar across treatment and placebo groups, which is a strong signal of overall tolerability. The trade-off is a higher likelihood of insomnia, dry mouth, and early restlessness, side effects that bother some people considerably but that others barely notice. Starting at a low dose and increasing slowly helps minimize the rough edges of the first few weeks.